← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2013Last known activity
Oct 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 8 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05969743Overall official - principal investigatorPhase 2Oct 1, 2023
- NCT04961229Lead sponsorPhase 4Oct 31, 2021
- NCT04756622Lead sponsorPhase 3Apr 1, 2021
- NCT04828525Lead sponsorPhase 3Apr 1, 2021
- NCT02797717Lead sponsorN/ANov 1, 2015
- NCT02362945Lead sponsorPhase 3Oct 1, 2015
- NCT02319707Lead sponsorPhase 3Sep 1, 2015
- NCT01732250Lead sponsorPhase 4Mar 1, 2013
Details
- Last known activity
- Oct 1, 2023